Tara Nealey, PhD
Shareholder, Vice Chair Biotechnology & Life Sciences Patent Practice
Dr. Tara Nealey is a shareholder in the St. Louis office of the Polsinelli law firm, and Vice Chair of the firm’s Biotechnology and Life Sciences Patent practice. With a background in academic physiology research, she focuses her law practice on advising clients with intellectual property questions related to life science technologies, including preparing and prosecuting patent applications, patentability reviews and opinions, freedom to operate and clearance, patent landscaping, and analysis of patent licenses. Her clients include individual inventors, public and private universities and research institutions, start-up companies, mid-size firms and Fortune 500 and Fortune 100 companies including generic and branded pharmaceutical companies.
Patent Wars: The CRISPR Patent Landscape
CRISPR is a relatively new genome editing tool that holds great promise for clinical and basic research applications across a wide range of life science industries. The question of who controls the foundational intellectual property rights to CRISPR is currently being addressed on multiple fronts in patent offices in the U.S. and around the world, leaving researchers confused about if and how to secure rights before using CRISPR. The talk will briefly summarize the CRISPR patent backstory, the current yet still evolving patent landscape, and prospects for major collaborative arrangements among the central CRISPR players that may make CRISPR more easily accessible.